[146] Apixaban is safer and more effective than rivaroxaban for non-valvular atrial fibrillation
Therapeutics Initiative,
Abstract Background: Non-valvular atrial fibrillation (NVAF) poses risks of mortality and thromboembolic events, necessitating…